Fusion Pharmaceuticals (FUSN)
(Delayed Data from NSDQ)
$21.40 USD
-0.02 (-0.09%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $21.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Fusion Pharmaceuticals Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -94.90 | -87.61 | -81.05 | -78.33 | -16.19 |
Depreciation/Amortization & Depletion | 1.35 | 0.91 | 0.63 | 0.48 | 0.29 |
Net Change from Assets/Liabilities | -1.32 | 3.66 | -14.60 | 5.74 | 3.09 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.07 | 9.77 | 19.27 | 42.35 | -0.88 |
Net Cash From Operating Activities | -81.80 | -73.28 | -75.74 | -29.77 | -13.69 |
Property & Equipment | -3.89 | -2.14 | -1.49 | -1.12 | -0.46 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -38.87 | 25.23 | 39.27 | -209.33 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -42.76 | 23.09 | 37.77 | -210.45 | -0.46 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 146.04 | 6.04 | 0.62 | 270.08 | 52.19 |
Issuance (Repayment) of Debt | 0.00 | 34.69 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -4.03 | 0.00 | -0.28 | -4.57 | 0.00 |
Net Cash from Financing Activities | 142.01 | 40.73 | 0.35 | 265.51 | 52.19 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 17.44 | -9.46 | -37.62 | 25.29 | 38.04 |
Cash at Beginning of Period | 45.33 | 54.79 | 92.41 | 67.12 | 29.08 |
Cash at End of Period | 62.77 | 45.33 | 54.79 | 92.41 | 67.12 |
Diluted Net EPS | -1.45 | -2.00 | -1.90 | -3.62 | -8.45 |
Fiscal Year End for Fusion Pharmaceuticals Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -94.90 | -66.72 | -49.47 | -24.29 |
Depreciation/Amortization & Depletion | NA | 1.35 | 0.98 | 0.61 | 0.27 |
Net Change from Assets/Liabilities | NA | -1.32 | -4.30 | -0.05 | -3.50 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 13.07 | 6.17 | 3.88 | 2.09 |
Net Cash From Operating Activities | NA | -81.80 | -63.86 | -45.02 | -25.44 |
Property & Equipment | NA | -3.89 | -2.41 | -1.93 | -1.22 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -38.87 | -35.11 | -48.91 | -23.31 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -42.76 | -37.52 | -50.85 | -24.53 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 146.04 | 88.18 | 87.83 | 63.37 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -4.03 | -4.03 | -4.00 | -3.86 |
Net Cash from Financing Activities | NA | 142.01 | 84.15 | 83.82 | 59.52 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 17.44 | -17.23 | -12.04 | 9.55 |
Cash at Beginning of Period | NA | 45.33 | 45.33 | 45.33 | 45.33 |
Cash at End of Period | NA | 62.77 | 28.11 | 33.29 | 54.89 |
Diluted Net EPS | NA | -0.37 | -0.25 | -0.38 | -0.45 |